Na-K-Cl cotransporter (NKCC) (NKCC)

The Na-K-Cl cotransporter (NKCC) is a membrane transport protein belonging to the solute carrier 12 (SLC12) family that mediates the secondary active transport of sodium, potassium, and chloride ions across cell membranes in a 1:1:2 stoichiometry [3, 11, 13]. It exists in two primary isoforms: NKCC1 (SLC12A2), which is ubiquitously expressed and crucial for cell volume regulation and exocrine fluid secretion, and NKCC2 (SLC12A1), which is specifically localized to the kidney's thick ascending limb of Henle [1, 7, 13]. NKCC2 serves as a critical therapeutic target for loop diuretics, such as furosemide and bumetanide, which inhibit the reabsorption of salt and water to treat hypertension, congestive heart failure, and edema [4, 14, 17]. Beyond its renal role, NKCC1 is increasingly recognized for its contribution to neuronal chloride homeostasis, making it a target of interest in the research of epilepsy, autism, and neuropathic pain [5, 15, 19]. Genetic mutations in NKCC2 lead to Type 1 Bartter syndrome, a condition characterized by severe salt wasting and electrolyte imbalances [10, 21]. Pharmacological modulation of these transporters requires careful monitoring due to potential side effects like hypokalemia, hyponatremia, and ototoxicity [14, 20].

Other names

Solute carrier family 12 member 1Solute carrier family 12 member 2SLC12A1SLC12A2NKCC1NKCC2Bumetanide-sensitive cotransporterBSC1BSC2Basolateral Na-K-Cl symporterKidney-specific Na-K-Cl symporter

Loop diuretics inhibit the Na-K-Cl cotransporter by binding to the chloride-binding site of the protein, preventing the electroneutral symport of sodium, potassium, and chloride ions across the cell membrane, which leads to natriuresis and diuresis [3, 11, 14].